Background: Recently different studies suggested that discontinuation of gonadotrophin releasing hormone analogue (GnRHa) at beginning of ovarian stimulation (improvement of ovarian response to gonadotrophins) may have some benefit to poor responder patients in invitro fertilization (IVF) cycles. Objective: The efficacy of GnRHa stop protocol in poor responder patients in IVF cycles was assessed. Materials and Methods: This study was a prospective, randomized controlled trial that 40 poor responder patients (less than three mature follicles in a previous cycle) with normal basal follicle stimulating hormone (FSH) were randomly allocated into two protocols: 1) Non-stop protocol: long GnRHa suppression, and start gonadotrophins from day 3...
BACKGROUND: Most reviews of IVF ovarian stimulation protocols have insufficiently accounted for vari...
The addition of gonadotropin releasing hormone analog (GnRH-a) to controlled ovarian hyperstimulatio...
The addition of gonadotropin releasing hormone analog (GnRH-a) to controlled ovarian hyperstimulatio...
Introduction and objective: This study aims to clarify if the GnRH agonist STOP-antagonist protocol ...
Introduction: Some patients exhibit a poor ovarian response when stimulated for IVF. Poor ovarian re...
Introduction: Between 5±18% of patients presents a low response when stimulated for IVF cycles. The ...
Objective To assess the efficacy of three different GnRH agonist (GnRH-a) stimulation regimens to im...
Objective To assess the efficacy of three different GnRH agonist (GnRH-a) stimulation regimens to im...
Background: Prolonged GnRH-a administration in IVF cycles may have some advantages related to the tr...
Objective To assess the efficacy of three different GnRH agonist (GnRH-a) stimulation regimens to im...
The aim of this prospective study was to evaluate the efficacy of gonadotrophin-releasing hormone an...
The aim of this prospective study was to evaluate the efficacy of gonadotrophin-releasing hormone an...
ObjectiveTo investigate whether delaying the start of ovarian stimulation with GnRH antagonist impro...
Background: Prolonged GnRH-a administration in IVF cycles may have some advantages related to the tr...
Background: Prolonged GnRH-a administration in IVF cycles may have some advantages related to the tr...
BACKGROUND: Most reviews of IVF ovarian stimulation protocols have insufficiently accounted for vari...
The addition of gonadotropin releasing hormone analog (GnRH-a) to controlled ovarian hyperstimulatio...
The addition of gonadotropin releasing hormone analog (GnRH-a) to controlled ovarian hyperstimulatio...
Introduction and objective: This study aims to clarify if the GnRH agonist STOP-antagonist protocol ...
Introduction: Some patients exhibit a poor ovarian response when stimulated for IVF. Poor ovarian re...
Introduction: Between 5±18% of patients presents a low response when stimulated for IVF cycles. The ...
Objective To assess the efficacy of three different GnRH agonist (GnRH-a) stimulation regimens to im...
Objective To assess the efficacy of three different GnRH agonist (GnRH-a) stimulation regimens to im...
Background: Prolonged GnRH-a administration in IVF cycles may have some advantages related to the tr...
Objective To assess the efficacy of three different GnRH agonist (GnRH-a) stimulation regimens to im...
The aim of this prospective study was to evaluate the efficacy of gonadotrophin-releasing hormone an...
The aim of this prospective study was to evaluate the efficacy of gonadotrophin-releasing hormone an...
ObjectiveTo investigate whether delaying the start of ovarian stimulation with GnRH antagonist impro...
Background: Prolonged GnRH-a administration in IVF cycles may have some advantages related to the tr...
Background: Prolonged GnRH-a administration in IVF cycles may have some advantages related to the tr...
BACKGROUND: Most reviews of IVF ovarian stimulation protocols have insufficiently accounted for vari...
The addition of gonadotropin releasing hormone analog (GnRH-a) to controlled ovarian hyperstimulatio...
The addition of gonadotropin releasing hormone analog (GnRH-a) to controlled ovarian hyperstimulatio...